Crabel Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Crabel Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-105,792	Closed	-$4.16M	–	131
2023 Q2	$4.16M	Buy	+105,792	New	+$3.73M	1.72%	23

Crabel Capital Management's ISEE Position: Q3 2023 in Review

Crabel Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 105,792 shares — an estimated $4.16M sold.

Crabel Capital Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $4.16M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Crabel Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Crabel Capital Management sold 105,792 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $4.16M.
Crabel Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Crabel Capital Management's IVERIC bio, Inc. Common Stock position peaked at $4.16M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Crabel Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.